These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11182497)

  • 1. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination.
    de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Microbiol; 2001 Feb; 78(4):307-17. PubMed ID: 11182497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs.
    Uttenthal A; Le Potier MF; Romero L; De Mia GM; Floegel-Niesmann G
    Vet Microbiol; 2001 Nov; 83(2):85-106. PubMed ID: 11557151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimeric (marker) C-strain viruses induce clinical protection against virulent classical swine fever virus (CSFV) and reduce transmission of CSFV between vaccinated pigs.
    de Smit AJ; Bouma A; van Gennip HG; de Kluijver EP; Moormann RJ
    Vaccine; 2001 Jan; 19(11-12):1467-76. PubMed ID: 11163670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intradermally administrated E2 subunit vaccines in reducing horizontal transmission of classical swine fever virus.
    Dortmans JC; Loeffen WL; Weerdmeester K; van der Poel WH; de Bruin MG
    Vaccine; 2008 Feb; 26(9):1235-42. PubMed ID: 18242794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of transplacental transmission of moderate-virulent classical swine fever virus after single or double vaccination with an E2 subunit vaccine.
    de Smit AJ; Bouma A; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Q; 2000 Jul; 22(3):150-3. PubMed ID: 10952445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a classical swine fever subunit marker vaccine and companion diagnostic test.
    Moormann RJ; Bouma A; Kramps JA; Terpstra C; De Smit HJ
    Vet Microbiol; 2000 Apr; 73(2-3):209-19. PubMed ID: 10785329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral immunisation against classical swine fever (CSF): onset and duration of immunity.
    Kaden V; Lange B
    Vet Microbiol; 2001 Oct; 82(4):301-10. PubMed ID: 11506924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidate peptide vaccine induced protection against classical swine fever virus.
    Dong XN; Wei K; Liu ZQ; Chen YH
    Vaccine; 2002 Dec; 21(3-4):167-73. PubMed ID: 12450690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma induction correlates with protection by DNA vaccine expressing E2 glycoprotein against classical swine fever virus infection in domestic pigs.
    Tarradas J; Argilaguet JM; Rosell R; Nofrarías M; Crisci E; Córdoba L; Pérez-Martín E; Díaz I; Rodríguez F; Domingo M; Montoya M; Ganges L
    Vet Microbiol; 2010 Apr; 142(1-2):51-8. PubMed ID: 19896784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection.
    Suradhat S; Intrakamhaeng M; Damrongwatanapokin S
    Vet Immunol Immunopathol; 2001 Dec; 83(3-4):177-89. PubMed ID: 11730928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commercial E2 subunit vaccine provides full protection to pigs against lethal challenge with 4 strains of classical swine fever virus genotype 2.
    Gong W; Li J; Wang Z; Sun J; Mi S; Xu J; Cao J; Hou Y; Wang D; Huo X; Sun Y; Wang P; Yuan K; Gao Y; Zhou X; He S; Tu C
    Vet Microbiol; 2019 Oct; 237():108403. PubMed ID: 31585656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of the classical swine fever (CSF) marker vaccine Porcilis Pesti in pregnant sows.
    Ahrens U; Kaden V; Drexler C; Visser N
    Vet Microbiol; 2000 Nov; 77(1-2):83-97. PubMed ID: 11042402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the marker vaccine rAdV-SFV-E2 against classical swine fever in the presence of maternally derived antibodies to rAdV-SFV-E2 or C-strain.
    Xia SL; Xiang GT; Lei JL; Du M; Wang Y; Zhou M; Liu Y; Ji S; Wang YL; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Nov; 196():50-54. PubMed ID: 27939155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and stability of a subunit vaccine based on glycoprotein E2 of classical swine fever virus.
    Bouma A; de Smit AJ; de Kluijver EP; Terpstra C; Moormann RJ
    Vet Microbiol; 1999 Apr; 66(2):101-14. PubMed ID: 10227472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A promising multiple-epitope recombinant vaccine against classical swine fever virus.
    Tian H; Hou X; Wu J; Chen Y; Shang Y; Yin S; Zhang K; Liu X
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):59-64. PubMed ID: 24269058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of pigs against classical swine fever. Course of the disease and virus transmission after simultaneous vaccination and infection.
    Kaden V; Schurig U; Steyer H
    Acta Virol; 2001 Feb; 45(1):23-9. PubMed ID: 11394574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.
    de Smit AJ
    Vet Q; 2000 Oct; 22(4):182-8. PubMed ID: 11087126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunisation of swine with a classical swine fever vaccine (Chinese strain) and transmission studies in rabbits and sheep.
    Chenut G; Saintilan AF; Burger C; Rosenthal F; Crucière C; Picard M; Bruyère V; Albina E
    Vet Microbiol; 1999 Feb; 64(4):265-76. PubMed ID: 10063532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yeast expressed classical swine fever E2 subunit vaccine candidate provides complete protection against lethal challenge infection and prevents horizontal virus transmission.
    Lin GJ; Deng MC; Chen ZW; Liu TY; Wu CW; Cheng CY; Chien MS; Huang C
    Vaccine; 2012 Mar; 30(13):2336-41. PubMed ID: 22300723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge.
    Ganges L; Barrera M; Núñez JI; Blanco I; Frias MT; Rodríguez F; Sobrino F
    Vaccine; 2005 May; 23(28):3741-52. PubMed ID: 15882536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.